A systematic review of artificial intelligence techniques in cancer prediction and diagnosis

Y Kumar, S Gupta, R Singla, YC Hu - Archives of Computational Methods …, 2022 - Springer
Artificial intelligence has aided in the advancement of healthcare research. The availability
of open-source healthcare statistics has prompted researchers to create applications that aid …

Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation

M Katoh - International journal of molecular medicine, 2018 - spandidos-publications.com
β-catenin/CTNNB1 is an intracellular scaffold protein that interacts with adhesion molecules
(E-cadherin/CDH1, N-cadherin/CDH2, VE-cadherin/CDH5 and α-catenins), transmembrane …

Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell …

T Xu, M Huang, R Xia, X Liu, M Sun, L Yin… - Journal of hematology & …, 2014 - Springer
Background FENDRR is a long non-coding RNAs (lncRNA) that binds to polycomb
repressive complexe 2 (PRC2) to epigenetically regulate the expression of its target gene …

Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma

F Yang, X Xue, J Bi, L Zheng, K Zhi, Y Gu… - Journal of cancer research …, 2013 - Springer
Abstract Purpose Long noncoding RNAs (lncRNAs) have been shown to have functional
roles in cancer biology and are deregulated in many tumors. The specific aim of this study …

Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis

W Kang, JHM Tong, AWH Chan, TL Lee… - Clinical Cancer …, 2011 - AACR
Abstract Purpose: Yes-associated protein 1 (YAP1) is a multifunctional protein that can
interact with different transcription factors to activate gene expression. The role of YAP1 in …

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer

T Bou Kheir, E Futoma-Kazmierczak, A Jacobsen… - Molecular cancer, 2011 - Springer
Background Gastric cancer is the fourth most common cancer in the world and the second
most prevalent cause of cancer related death. The development of gastric cancer is mainly …

An investigational approach for the prediction of gastric cancer using artificial intelligence techniques: a systematic review

P Bhardwaj, G Bhandari, Y Kumar, S Gupta - Archives of Computational …, 2022 - Springer
Gastric cancer is characterized by the growth of cancerous cells within the lining of the
stomach. Traditionally, this condition has been challenging to diagnose. However, today …

Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers

HH Wu, W Lin, KW Tsai - Expert reviews in molecular medicine, 2014 - cambridge.org
Carcinoma of the stomach is one of the most prevalent cancer types in the world. Although
the incidence of gastric cancer is declining, the outcomes of gastric cancer patients remain …

Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer

G Corso, J Carvalho, D Marrelli, C Vindigni… - Journal of clinical …, 2013 - ascopubs.org
Purpose The prognosis of gastric cancer (GC) is poor, and the molecular pathogenesis
players are vastly unknown. Surgery remains the primary option in GC treatment. The aim of …

Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment

F Islam, V Gopalan, RA Smith, AKY Lam - Experimental cell research, 2015 - Elsevier
Cancer stem cells (CSCs) are a subpopulation of cancer cells with many clinical implications
in most cancer types. One important clinical implication of CSCs is their role in cancer …